Skip to main content
Fig. 2 | Cancer & Metabolism

Fig. 2

From: Targeting glutamine metabolism sensitizes pancreatic cancer to PARP-driven metabolic catastrophe induced by ß-lapachone

Fig. 2

Inhibiting glutamine metabolism sensitizes PDA to ß-lap. a Colony formation assay of MiaPaCa2 cells depleted of glutamine for 16 h, followed by treatment with ß-lap for 2 h. p < 0.01 at 3 μM and p < 0.0001 at 4 μM. bf Glutamine deprivation experiments with a dose range of ß-lap in ASPC1, MPanc96, HPAFII, SW1990, and DAN-G PDA cell lines. g ß-lap dose response in MiaPaCa2 cells with knockdown of GLS1. h Western blots for GLS1, ME1, GOT1, and GLUD1 upon knockdown in MiaPaCa2 cell lines for 48 h using siRNA. i Relative survival of GOT1, GLS1, GLUD1, and ME1 MiaPaCa2 knockdown cells treated with 2.5 μM ß-lap for 2 h. j, k GLS1 was knocked down in MiaPaCa2, and either 3 mM oxaloacetate (OAA) or 3 mM dimethyl malate was added for 24 h followed by a 2-h treatment with 2.5 μM ß-lap. Relative survival represents means of CellTiter-Glo survival assay 48 h after treatment plotted as percentage treated/control (T/C), ±SE from sextuplicate samples. All results were compared using Student’s t tests. *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001

Back to article page